Heath-Chiozzi Margo's Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Jun 3, 2024
- Accession no.
- 0001415889-24-015148
- Filed
- Jun 3, 2024
- Trade date
- May 30, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.32M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heath-Chiozzi MargoCIK 0001718112 | Officer (SVP OF REGULATORY AFFAIRS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | Common Stock | MOption exerciseAcquired | +29,068 | $2.78 | +$80,809.04 | 41,162 | Direct | |
| May 30, 2024 | Common Stock | MOption exerciseAcquired | +2,043 | $9.02 | +$18,427.86 | 43,205 | Direct | |
| May 30, 2024 | Common Stock | MOption exerciseAcquired | +2,608 | $10.38 | +$27,071.04 | 45,813 | Direct | |
| May 30, 2024 | Common Stock | SSaleDisposed | −38,719 | $34.07 | −$1,319,156.33 | 7,094 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | Common Stock | MOption exerciseDisposed | −29,068 | $0.00 | $0 | 12,732 | Direct | |
| May 30, 2024 | Common Stock | MOption exerciseDisposed | −2,043 | $0.00 | $0 | 6,289 | Direct | |
| May 30, 2024 | Common Stock | MOption exerciseDisposed | −2,608 | $0.00 | $0 | 81,392 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.